Photosynthesis-Based Enhancement of Plant Disease Resistance via CRISPR Gene Editing

Overview

This research explores the relationship between photosynthesis and plant disease resistance, aiming to uncover how photosynthetic efficiency can be enhanced to improve crop resilience against bacterial pathogens. The work addresses a critical gap in agricultural science: while infected plants require increased energy and assimilates to mount a defense, photosynthesis typically declines during infection. By identifying the genetic and metabolic hubs connecting photosynthesis to disease resistance, this program seeks to develop strategies for improving both crop health and yield.

The ultimate goal is to translate findings from model organism Arabidopsis thaliana into practical applications for soybean crops, offering a pathway to improved disease resistance and agricultural productivity.

Technical specifications

Research approach:

• Use of CRISPR/Cas9 technology to knock out key genes in the carbon fixation pathway, enabling observation of how reduced photosynthetic capacity affects disease resistance in mutant plants
• Investigation of whether enhancing photosynthetic efficiency directly increases plant disease resistance
• Application of metabolomics to screen for metabolite changes that serve as hubs between photosynthesis and pathogen defense
• Use of transcriptomics and proteomics to identify key transcription factors and proteins regulating the photosynthesis-disease resistance relationship
• Translation of regulatory mechanisms from Arabidopsis thaliana to soybean crops for improved disease resistance and yield

Key scientific rationale:

• Bacterial infection triggers increased respiratory rates in plants to generate ATP for defense responses
• Infected plants require enhanced photosynthetic rates and efficiency to meet elevated assimilate demands
• Despite this need, photosynthesis generally decreases during infection, creating a metabolic conflict that limits disease resistance

Technology readiness level

This research is at an early discovery stage, with hypotheses developed based on observed physiological responses in Arabidopsis thaliana seedlings following pathogen infection. The proposed validation plan outlines a systematic approach using CRISPR/Cas9 gene editing combined with multi-omics analyses. Application to soybean crops represents the long-term translational goal, contingent on successful gene and metabolite identification in the model system. The program is positioned for collaborative partnerships to advance validation and crop translation.